NEW IDEAS, OLD PROBLEMS? HEATED TOBACCO PRODUCTS--A SYSTwMATIC REVIEW. - Document - Gale OneFile: Health and Medicine
![Surfactant protein D attenuates acute lung and kidney injuries in pneumonia-induced sepsis through modulating apoptosis, inflammation and NF-κB signaling | Scientific Reports Surfactant protein D attenuates acute lung and kidney injuries in pneumonia-induced sepsis through modulating apoptosis, inflammation and NF-κB signaling | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-018-33828-7/MediaObjects/41598_2018_33828_Fig7_HTML.png)
Surfactant protein D attenuates acute lung and kidney injuries in pneumonia-induced sepsis through modulating apoptosis, inflammation and NF-κB signaling | Scientific Reports
![In-line treatments and clinical initiatives to fight against COVID-19 outbreak - Respiratory Medicine In-line treatments and clinical initiatives to fight against COVID-19 outbreak - Respiratory Medicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/83533f55-3de7-4d53-89f8-a478ed7b18b5/gr6_lrg.jpg)
In-line treatments and clinical initiatives to fight against COVID-19 outbreak - Respiratory Medicine
![Lipid metabolism impairment in patients with sepsis secondary to hospital acquired pneumonia, a proteomic analysis | Clinical Proteomics | Full Text Lipid metabolism impairment in patients with sepsis secondary to hospital acquired pneumonia, a proteomic analysis | Clinical Proteomics | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12014-019-9252-2/MediaObjects/12014_2019_9252_Fig1_HTML.png)
Lipid metabolism impairment in patients with sepsis secondary to hospital acquired pneumonia, a proteomic analysis | Clinical Proteomics | Full Text
![Immunothrombotic Dysregulation in COVID-19 Pneumonia Is Associated With Respiratory Failure and Coagulopathy | Circulation Immunothrombotic Dysregulation in COVID-19 Pneumonia Is Associated With Respiratory Failure and Coagulopathy | Circulation](https://www.ahajournals.org/cms/asset/b6cd3103-7eb5-456e-a9f0-1bd89e0f7493/circulationaha.120.048488.fig02.jpg)
Immunothrombotic Dysregulation in COVID-19 Pneumonia Is Associated With Respiratory Failure and Coagulopathy | Circulation
![Surfactant protein D attenuates acute lung and kidney injuries in pneumonia-induced sepsis through modulating apoptosis, inflammation and NF-κB signaling | Scientific Reports Surfactant protein D attenuates acute lung and kidney injuries in pneumonia-induced sepsis through modulating apoptosis, inflammation and NF-κB signaling | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-018-33828-7/MediaObjects/41598_2018_33828_Fig2_HTML.png)
Surfactant protein D attenuates acute lung and kidney injuries in pneumonia-induced sepsis through modulating apoptosis, inflammation and NF-κB signaling | Scientific Reports
![Experimental study of multi-stable morphing structures actuated by pneumatic actuation | SpringerLink Experimental study of multi-stable morphing structures actuated by pneumatic actuation | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00170-020-05301-1/MediaObjects/170_2020_5301_Fig11_HTML.png)
Experimental study of multi-stable morphing structures actuated by pneumatic actuation | SpringerLink
![Oral Care Intervention to Reduce Incidence of Ventilator-Associated Pneumonia in the Neurologic Intensive Care Unit | Article | NursingCenter Oral Care Intervention to Reduce Incidence of Ventilator-Associated Pneumonia in the Neurologic Intensive Care Unit | Article | NursingCenter](https://www.nursingcenter.com/wkhlrp/handlers/Cv.png?key=cv_01376517-200810000-00000)
Oral Care Intervention to Reduce Incidence of Ventilator-Associated Pneumonia in the Neurologic Intensive Care Unit | Article | NursingCenter
![A phase 3 trial of safety, tolerability, and immunogenicity of V114, 15-valent pneumococcal conjugate vaccine, compared with 13-valent pneumococcal conjugate vaccine in adults 50 years of age and older (PNEU-AGE) - ScienceDirect A phase 3 trial of safety, tolerability, and immunogenicity of V114, 15-valent pneumococcal conjugate vaccine, compared with 13-valent pneumococcal conjugate vaccine in adults 50 years of age and older (PNEU-AGE) - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0264410X21010975-gr3.jpg)